rs747166010
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_017775.4(TTC19):c.656T>G(p.Leu219*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000628 in 1,607,518 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_017775.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTC19 | NM_017775.4 | c.656T>G | p.Leu219* | stop_gained | 7/10 | ENST00000261647.10 | NP_060245.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTC19 | ENST00000261647.10 | c.656T>G | p.Leu219* | stop_gained | 7/10 | 1 | NM_017775.4 | ENSP00000261647.5 | ||
TTC19 | ENST00000475723.5 | n.*340T>G | non_coding_transcript_exon_variant | 7/10 | 2 | ENSP00000465754.1 | ||||
TTC19 | ENST00000497842.6 | n.766T>G | non_coding_transcript_exon_variant | 6/10 | 5 | |||||
TTC19 | ENST00000475723.5 | n.*340T>G | 3_prime_UTR_variant | 7/10 | 2 | ENSP00000465754.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251354Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135856
GnomAD4 exome AF: 0.0000653 AC: 95AN: 1455342Hom.: 0 Cov.: 29 AF XY: 0.0000690 AC XY: 50AN XY: 724466
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152176Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74354
ClinVar
Submissions by phenotype
Mitochondrial complex III deficiency nuclear type 2 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 31, 2023 | Variant summary: TTC19 c.656T>G (p.Leu219X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 6.4e-05 in 251354 control chromosomes (gnomAD). c.656T>G has been reported in the literature in multiple homozygous individuals affected with Mitochondrial Complex III Deficiency (example: Ghezzi_2011). These data indicate that the variant is very likely to be associated with disease. The following publication has been ascertained in the context of this evaluation (PMID: 21278747). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2011 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 24, 2024 | Significantly reduced levels of mutant transcript and absent TTC19 protein have been reported in homozygous patient cells, suggesting mutant transcripts are subject to nonsense-mediated decay (PMID: 21278747, 25887401); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25899669, 25525159, 25887401, 21278747) - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Oct 23, 2020 | - - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 14, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at